跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED DISODIUM FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PEMETREXED DISODIUM FOR INJECTION
Authorized
STANDARD
PEMETREXED DISODIUM FOR INJECTION
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
db4ec35cbe2f2595
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
db4ec35cbe2f2595
Drug Approval Canada Name
PEMETREXED DISODIUM FOR INJECTION
Product Name
PEMETREXED DISODIUM FOR INJECTION
Status
Marketed
Status Date
2017-03-31
Original Market Date
2017-03-31
Din
02459434
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BA04 PEMETREXED
Atc Name
l 01 ba 04
Aig Number
0150104002
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
PEMETREXED (PEMETREXED DISODIUM)
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
db4ec35cbe2f2595
Type
Standard
Back to Health Canada Approvals